Eli Lilly Beats Cymbalta Withdrawal Risk Suit

Law360, New York (April 17, 2015, 4:19 PM EDT) -- Eli Lily Pharmaceutal Co. persuaded a Texas federal court Thursday to throw out a proposed class action by a woman claiming its antidepressant Cymbalta caused withdrawal symptoms that she said the drugmaker did not sufficiently warn about.

U.S. District Judge Lee H. Rosenthal granted Eli Lilly's motion to dismiss, agreeing with the drugmaker that plaintiff Marilyn Pickaree exceeded the two-year statute of limitations for personal injury actions under Texas law. Pickaree, who alleged she suffered significant withdrawal effects in the days after she stopped taking Cymbalta...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Pickaree v. Eli Lily Pharmaceutal Company


Case Number

4:14-cv-03481

Court

Texas Southern

Nature of Suit

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)

Judge

Judge Lee H Rosenthal

Date Filed

December 4, 2014

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.